PHENPath.com is highlighted by Amgen.com in their recently published article, “Building Towards Patient-Centered Clinical Pathways”

by | May 24, 2021 | Company News

PHENPath.com helps Prostate Cancer patients understand their treatment pathways and treatment options. Prostate Cancer diagnosis, Treatment Options, PSA Recurrence after Radical Prostatectomy, Progression After Radiation, Hormone Sensitive Cancer, Castration Resistent Cancer, Low Risk, Very Low Risk, Intermediate Risk, High Risk, Very High Risk, Metastatic, Regional, Prostate Cancer Diagnosis, Testing, Treatment Therapies, Understanding your Risk Level

PHEN is a partner organization of the Amgen Clinical Pathways initiative, PHENPath.com helps empower prostate cancer patients through its first digital treatment pathway tool of its kind.

We encourage you to read the article by clicking the button link below

Read the Article


 

 

Pin It on Pinterest